REGEN-COV (casirivimab/imdevimab) - Regeneron, Roche
|
bebtelovimab (LY-CoV1404) - AbCellera, Eli Lilly
|
Evusheld (cilgavimab/tixagevimab) - AstraZeneca
|
bamlanivimab (LY-CoV555) - Eli Lilly, AbCellera, National Institute of Allergy and Infectious Diseases
|
Xevudy (sotrovimab) - GSK, National Institutes of Health, Vir Biotech, National Institute of Allergy and Infectious Diseases
|
etesevimab (JS016) - Chinese Academy of Sciences, Shanghai Junshi Biosci, Eli Lilly
|